(a) Two well known uses for combination therapies: to prevent the emergence of drug-resistant pathogens or tumor cells by simultaneously targeting multiple sites on a key protein (blue squiggle ...

A computational tool has accurately predicted a drug combination that inhibited triple-negative breast cancer in in vitro experiments. Researchers at the Icahn School of Medicine at Mount Sinai (NY, ...

The FDA granted an orphan drug designation to PEP-010 for the treatment of patients with metastatic pancreatic cancer.

A novel oral combination drug therapy evaluated at Huntsman Cancer Institute could treat and prevent melanoma spreading to ...